Keith Regnante, Chief Financial Officer at Wave Life Sciences Ltd. (WVE), sold 29,500 shares at $55.00 ($1.6M) on 2018-09-24, disclosed to the SEC on 2018-09-26.
Open-market sale of $1.6M WVE by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| KROS | SELL | 2024-01-08 | $1.8M | — | Filing → |
| KROS | SELL | 2023-06-12 | $3.7M | — | Filing → |
| WVE | SELL | 2019-02-21 | $48K | — | Filing → |